394 related articles for article (PubMed ID: 9021999)
1. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
[TBL] [Abstract][Full Text] [Related]
2. Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells.
Lombardi G; Sidhu S; Dodi T; Batchelor R; Lechler R
Eur J Immunol; 1994 Mar; 24(3):523-30. PubMed ID: 7510233
[TBL] [Abstract][Full Text] [Related]
3. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
[TBL] [Abstract][Full Text] [Related]
4. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
Morokata T; Kato T; Igarashi O; Nariuchi H
Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
[TBL] [Abstract][Full Text] [Related]
7. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
8. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
Croft M; Swain SL
J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
[TBL] [Abstract][Full Text] [Related]
9. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.
Geppert TD; Lipsky PE
J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840
[TBL] [Abstract][Full Text] [Related]
10. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
Umetsu DT; Katzen D; Jabara HH; Geha RS
J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
[TBL] [Abstract][Full Text] [Related]
11. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
12. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
13. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
Walter H; Schepensn S; Van Wauwe J; de Boer M
Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
[TBL] [Abstract][Full Text] [Related]
14. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
15. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
16. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands.
Kaneda R; Iwabuchi K; Kasai M; Murakami M; Uede T; Onoé K
Cell Immunol; 1997 Nov; 181(2):163-71. PubMed ID: 9398403
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation by keratinocytes induces tolerance in human T cells.
Bal V; McIndoe A; Denton G; Hudson D; Lombardi G; Lamb J; Lechler R
Eur J Immunol; 1990 Sep; 20(9):1893-7. PubMed ID: 2120067
[TBL] [Abstract][Full Text] [Related]
18. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.
Galvin F; Freeman GJ; Razi-Wolf Z; Hall W; Benacerraf B; Nadler L; Reiser H
J Immunol; 1992 Dec; 149(12):3802-8. PubMed ID: 1281187
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]